Cart
sales@molnova.com
10-Formyl-5,8-dideazafolic acid
CAS No. 61038-31-1
10-Formyl-5,8-dideazafolic acid( —— )
Catalog No. M35686 CAS No. 61038-31-1
10-Formyl-5,8-dideazafolic acid (CB3717) is a water-soluble analog of folic acid, also known as folate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 379 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name10-Formyl-5,8-dideazafolic acid
-
NoteResearch use only, not for human use.
-
Brief Description10-Formyl-5,8-dideazafolic acid (CB3717) is a water-soluble analog of folic acid, also known as folate.
-
Description10-Formyl-5,8-dideazafolic acid is a thymidylate synthase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61038-31-1
-
Formula Weight467.43
-
Molecular FormulaC22H21N5O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (106.97 mM; Ultrasonic )
-
SMILESNc1nc(=O)c2cc(CN(C=O)c3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)ccc2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Reddy MR, et, al. Calculation of solvation and binding free energy differences for folate-based inhibitors of the enzyme thymidylate synthase. J. Am. Chem. Soc. 1992, 114, 26, 10117-10122.
molnova catalog
related products
-
Thymectacin
Thymectacin (NB 1011) is a selective thymidine synthase (TS) inhibitor with anticancer activity for the study of colon cancer and solid tumors.
-
dADP disodium
dADP disodium (2'-Deoxyadenosine 5'-di-phos-phate disodium) is widely found in plants and animals, competitively inhibits bacterial poly(A) polymerase, and is involved in the body's energy cycle.
-
Sarmustine
Sarmustine (SarCNU) is an alkylating agent with anticancer activity that inhibits the growth of prostate cancer cells via p53-dependent and p53-independent pathways.
